An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

Part of paid clinical trials in Miami, Florida.

Sponsor
Qbtech AB
Study ID
NCT07329673
Status
Recruiting
Apply to this trial

Conditions

  • Autism Spectrum Disorder (ASD)
  • Bi-Polar Disorder
  • Generalized Anxiety Disorder (GAD)
  • Major Depression Disorders
  • Separation Anxiety Disorder
  • Social Anxiety Disorder

Eligibility Criteria

Sex
ALL
Age
6 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • Digital software application for cognitive performance and activity measurement (QbMobile, investigational device) — DEVICE
    Participants will complete two non-invasive, 10-minute digital tests using the QbMobile Investigational Device-one at the clinic and one at home the following day. The tests objectively measure cognitive performance and activity levels and will not influence clinical diagnosis or treatment in this study.

Study Details

The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.

Key Dates

Start date
Jan 1, 2026
Status verified
May 2026
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: ASD
    Eligible participants being referred for their initial assessment or have a diagnosis of ASD but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.
  • Arm: Bipolar disorder
    Eligible participants being referred for their initial assessment or have a diagnosis of Bipolar Disorder but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.
  • Arm: MDD
    Eligible participants being referred for their initial assessment or have a diagnosis of MDD but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.
  • Arm: Separation Anxiety Disorder
    Eligible participants being referred for their initial assessment or have a diagnosis of Separation Anxiety Disorder but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.
  • Arm: Social Anxiety Disorder
    Eligible participants being referred for their initial assessment or have a diagnosis of Social Anxiety Disorder but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.
  • Arm: Generalized Anxiety Disorder
    Eligible participants being referred for their initial assessment or have a diagnosis of Generalized Anxiety Disorder but currently not receiving treatment who are attending a clinic visit at study sites will be approached by a clinic research staff about the study or contacted prior to their appointment.

Primary Outcome Measure

Identification of QbMobile Domain Profiles Using SD-Scores and Total Score (0-100) [ Time Frame: Two QbMobile tests: at the clinic (Visit 1) and remotely the following day (Visit 2) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
CCM Clinical Research GroupMiamiFlorida33133
CCM Clinical Research Group
[email protected]
305-285-0705
Francisco Ricart, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Miami, FL

By research site
CCM Clinical Research Group· Miami, FL

Related Studies